[Evidentic] Daratumumab
GHS0702
- Product Concentration
- 20 mg/mL
- Volume per vial
- 100 µL
- Quantity per vial
- 2 mg
- Batch Number
- GHS0702
- Storage Temperature
- -80°C
Target
Class of molecule
Isotype
Host cells
Chinese Hamster Ovary (CHO) cells
Prepared from (Reference drug)
Darzalex®
Therapeutic Area
Therapeutic Indications
Mechanism of Action (MoA)
Utilises multiple effector functions ADCC, ADCP and CDC, resulting in immune mediated tumour cell death.
Evidentic offers repackaged finished pharmaceutical products (e.g RMP/RLD). We refer to the repackaged RMP/RLD products synonymously as drug aliquots or aRMP, or short: aliquots.
We offer batches of original drug aliquots in low-binding Eppendorf tubes for research use only. We provide license-free drug aliquots with long, short or even “negative shelf life” by storing the products at recommended temperatures (either 2-8°C or -80°C) and ensuring fully functional molecules for research purposes.
'Evidentic' 카테고리의 다른 글
[Evidentic] Adalimumab (0) | 2023.04.27 |
---|---|
[Evidentic] Alemtuzumab (0) | 2022.09.26 |
[Evidentic] Bevacizumab (0) | 2022.08.16 |
[Evidentic] Adalimumab (0) | 2022.05.25 |
[Evidentic] Adalimumab (0) | 2022.04.25 |